Eppendorf
Falk Schneider has extensive work experience, starting in 1998 as the Co-Founder and General Manager of DASGIP AG. Falk held this role until 2011. From 2012 to 2019, they served as the Managing Director of DASGIP Information and Process Technology GmbH. In 2020, they joined Eppendorf Group as the Head of Bioprocess Software and Automation, a role they held until the end of the year. In 2021, they became the Senior Director Bioprocess Software & Proxy at Eppendorf Group. Finally, starting in 2023, they assumed the position of Head of Global Bioprocess Portfolio at Eppendorf Group.
Falk Schneider earned a Dr.-Ing. degree in Electrical Engineering from RWTH Aachen University, completing their education from 1986 to 1998.
This person is not in any teams
Eppendorf
5 followers
Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers, and DNA amplification equipment as well as ultra-low temperature freezers, fermentors, bioreactors, CO2 incubators, shakers, and cell manipulation systems. Consumables such as pipette tips, test tubes, microtiter plates, and disposable bioreactors complement the range of highest-quality premium products. Eppendorf products are most broadly used in academic and commercial research laboratories, e.g., in companies from the pharmaceutical and biotechnological as well as the chemical and food industries. They are also aimed at clinical and environmental analysis laboratories, forensics, and industrial laboratories performing process analysis, production, and quality assurance. Eppendorf was founded in Hamburg, Germany in 1945 and has about 4,500 employees worldwide. The company has subsidiaries in 33 countries and is represented in all other markets by distributors. Imprint: www.eppendorf.com/imprint